The states with the next highest relative levels of corporate output were Delaware (13.9 percent), California (13.2 percent) and New York (10.9 percent).
According to the report, “8,830 publications or 26.4 percent of all of New Jersey’s corporate publications were in the field of medicine, the highest among all fields. More significantly, research in pharmacology, toxicology and pharmaceutics comprised 15.2 percent of New Jersey corporate publications, twice the rate of the state’s total research output (6.0 percent) and that of the U.S. total corporate research output (7.4 percent). There is a high concentration of pharmaceutical companies—and particularly their R&D operations—in New Jersey, and these measures suggest that they play an outsized role in driving New Jersey’s larger research ecosystem, both vis-à-vis its universities and its research corporations in other industries.”
The report also noted that “after medicine, New York and New Jersey collaborated the most in physics and astronomy. Collaborations in that field comprised 19.4 percent of all New York to New Jersey co-authored papers, even though only 11.3 percent of New York’s total research output was in physics and astronomy.
For the full report: http://www.csg.org/programs/knowledgeeconomy/background.aspx